دورية
Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study
| العنوان: | Clinical Activity of BMS-986393 (CC-95266), a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma (MM): First Results from a Phase 1, Multicenter, Open-Label Study |
|---|---|
| المؤلفون: | Bal, Susan, Kocoglu, M. Hakan, Nadeem, Omar, Htut, Myo, Gregory, Tara, Anderson, Larry D., Costa, Luciano J., Buchholz, Tonia J., Ziyad, Safiyyah, Li, Meng, Chen, Yanping, Kaeding, Allison J., Burgess, Michael R., Hege, Kristen, Berdeja, Jesus |
| المصدر: | Blood; November 2022, Vol. 140 Issue: Supplement 1 p883-885, 3p |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 00064971 15280020 |
|---|---|
| DOI: | 10.1182/blood-2022-162395 |